Home › ISIS Pharmaceuticals: Another Entry Point
 

Keywords :   


ISIS Pharmaceuticals: Another Entry Point

2015-07-28 21:37:55| Chemicals - Topix.net

Like most biotech companies with little-to-no product revenue stream, the stock is quite volatile and driven largely by news flow. The company also benefits from several large pharmaceutical partners including J&J, Biogen Idec, Glaxo Smith Kline, Bayer, and Astra Zeneca.

Tags: point entry pharmaceuticals isis

Category:Chemicals

Latest from this category

All news
12.11Benjamin Moore Expands Partnership with Roadie to Accelerate Paint Delivery for DIYers and Pros
11.11Clariant Launches Melamine-free Flame Retardant for Intumescent Coatings
11.11Protech Group Acquires Caldwell Chemical Coatings
11.11Asian Paints Reports 2Q 2024-25 Fiscal Results
10.11Clariant Launches Melamine-free Flame Retardant for Intumescent Coatings
09.11Weekly Recap: Nippon Paint, AkzoNobel, PPG Top This Weeks Stories
Chemicals »
23.11 #249
23.11muta5
23.1120
23.11BabolaT VS BUG4300 24ss
23.11
23.11 TYO26cm
23.112
23.11CW-X 2.0
More »